Spago Nanomedical Interim Report January-March 2023

LUND, SE / ACCESSWIRE / May 09, 2023 / Spago Nanomedical (STO:SPAGO.ST) (FRA:7UX.F) Towards clinic with Tumorad®JANUARY - MARCH IN BRIEFNet sales for the quarter amounted to KSEK 88 (KSEK 211)The loss

Related Keywords

Australia ,Sweden ,San Antonio ,Texas ,United States ,Australian ,Swedish ,Hans Arwidsson ,Ligita Jokubkiene ,Spago Nanomedical ,Alan Raffensperger ,Spago Nanomedicalview ,Nicklas Westerholm ,World Congress On Endometriosis ,Australian Human Research Ethics ,Nanomedical Radiopharmaceutical ,World Congress ,Australian Human Research Ethics Committees ,San Antonio Breast Cancer Symposium ,Mats Hansen ,Nasdaq First North Growth Market ,Certified Adviser ,Gefallene Big Techs ,Spago ,Anomedical ,Interim ,Report ,January ,Arch ,023 ,